This opportunity is no longer accepting applications.
grant PAR-25-054

NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)

This grant opportunity invites applications for early-stage clinical trials related to neurological disorders and stroke, supported by the National Institute of Neurological Disorders and Stroke (NINDS). It focuses on Phase 1 and 2 studies of drugs and biologics, feasibility studies of devices, and early-stage research on surgical, behavioral, or rehabilitation therapies. The goal is to gather…

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Neurological Disorders and Stroke

Dates

Opportunity Released: November 12, 2024
Open for Submission: November 12, 2024
Submission Deadline: March 10, 2025
Application Window Closes: March 10, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.